Edition:
United States

Ibio Inc (IBIO.A)

IBIO.A on American Stock Exchange

0.39USD
21 Feb 2017
Change (% chg)

$-0.01 (-2.50%)
Prev Close
$0.40
Open
$0.38
Day's High
$0.39
Day's Low
$0.38
Volume
11,364
Avg. Vol
12,037
52-wk High
$0.80
52-wk Low
$0.34

IBIO.A

Chart for IBIO.A

About

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformati... (more)
No analyst recommendations are available for IBIO.A.

Overall

Beta: 1.31
Market Cap(Mil.): $35.00
Shares Outstanding(Mil.): 89.11
Dividend: --
Yield (%): --

Financials

  IBIO.A Industry Sector
P/E (TTM): -- 28.45 29.35
EPS (TTM): -0.13 -- --
ROI: -59.11 13.47 12.97
ROE: -130.03 14.36 14.11

BRIEF-iBio files for non timely 10-Q

* Ibio Inc - Files for non timely 10-Q Source text: [http://bit.ly/2lh0FiT] Further company coverage:

Feb 14 2017

BRIEF-IBIO reports issue of a new Canadian patent in company's ibiomodulator thermostable immunomodulator protein portfolio

* Announces issue of a new Canadian patent in company's ibiomodulator thermostable immunomodulator protein portfolio Source text for Eikon: Further company coverage:

Nov 21 2016

BRIEF-Ibio Inc - successful application of proprietary technologies agreement with Azargen Biotechnologies

* Successful application of proprietary technologies to achieve first milestone in commercial development agreement with Azargen Biotechnologies Source text for Eikon: Further company coverage:

Sep 29 2016

BRIEF-Ibio Inc files for non-timely 10-k

* Delay in 10-k due to delays in the collection and compilation of certain information required to be included in the form 10-k Source text for Eikon: Further company coverage:

Sep 28 2016

More From Around the Web

Competitors

Earnings vs. Estimates